SGLT2 inhibitor dapagliflozin alleviates intramyocardial hemorrhage and adverse ventricular remodeling via suppressing hepcidin in myocardial ischemia-reperfusion injury
Article in European Journal of Pharmacology (April 2023)
The most recent citing publications are shown below. View all 75 publications that cite this research output on Dimensions.
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
Article in Cardiovascular Diabetology (April 2023)
Geriatric nutritional risk index predicts all-cause mortality in the oldest-old patients with acute coronary syndrome: A 10-year cohort study
Article in Frontiers in Nutrition (March 2023)